Translational Lung Cancer Research

期刊简介：Translational Lung Cancer Research(TLCR, Transl Lung Cancer Res, Print ISSN 2218-6751; Online ISSN 2226-4477) is an international, peer-reviewed, open-access journal, which was founded in March 2012. TLCR is indexed by PubMed/PubMed Central and the Chemical Abstracts Service (CAS) Databases. It is published quarterly the first year, and published bimonthly since February 2013. It provides practical up-to-date information on prevention, early detection, diagnosis, and treatment of lung cancer. Specific areas of its interest include, but not limited to, multimodality therapy, markers, imaging, tumor biology, pathology, chemoprevention, and technical advances related to lung cancer.

【译文】转化性肺癌研究（TLCR，Transl Lung Cancer Res，印刷版ISSN 2218-6751；在线ISSN 2226-4477）是一本国际性的同行评审开放获取期刊，成立于2012年3月。TLCR被PubMed/PubMed Central和化学文摘服务（CAS）数据库收录。它在前一年是每季度出版一次，自2013年2月起改为双月出版。它提供了关于肺癌预防、早期检测、诊断和治疗的最新的实用信息。其感兴趣的具体领域包括但不限于多模式治疗、标志物、成像、肿瘤生物学、病理学、化学预防以及与肺癌相关的技术进步。